APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phage Display Library Screening Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phage Display Library Screening Services Market Outlook and Growth Opportunities 2026

15 January 2026206 pages

Choose your research edition.

Industry ResearchPhage Display Library Screening Services Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Phage Display Library Screening Services Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Phage Display Library Screening Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phage Display Library Screening Services Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Phage Display Library Screening Services Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Phage Display Library Screening Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phage Display Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phage Display Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phage Display Library Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phage Display Library Screening Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phage Display Library Screening Services market include Creative Biolabs, Cusabio, Elabscience, Biomolecular Discovery Services, Sino Biological, VectorBuilder, ProteoGenix, IRBM and KMD Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Phage Display Library Screening Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phage Display Library Screening Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phage Display Library Screening Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Phage Display Library Screening Services market.

Phage Display Library Screening Services Segment by Company

Creative Biolabs

Cusabio

Elabscience

Biomolecular Discovery Services

Sino Biological

VectorBuilder

ProteoGenix

IRBM

KMD Bioscience

Fusion BioLabs

WuXi Biologics

Selvita

Alpha Lifetech

Creative Peptides

MtoZ Biolabs

Creative BioMart Microbe

Nanjing Zoonbio Biotechnology

Phage Display Library Screening Services Segment by Type

Solid-Phase Screening

Solution-Phase Screening

Others

Phage Display Library Screening Services Segment by Application

Therapeutic Development

Diagnostic Development

Research

Phage Display Library Screening Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Phage Display Library Screening Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Phage Display Library Screening Services key companies, revenue, market share, and recent developments.

3. To split the Phage Display Library Screening Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Phage Display Library Screening Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phage Display Library Screening Services significant trends, drivers, influence factors in global and regions.

6. To analyze Phage Display Library Screening Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Display Library Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phage Display Library Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Display Library Screening Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phage Display Library Screening Services industry.

Chapter 3: Detailed analysis of Phage Display Library Screening Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Phage Display Library Screening Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Phage Display Library Screening Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phage Display Library Screening Services Industry Trends Table 2. Phage Display Library Screening Services Industry Drivers Table 3. Phage Display Library Screening Services Industry Opportunities and Challenges Table 4. Phage Display Library Screening Services Industry Restraints Table 5. Global Phage Display Library Screening Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phage Display Library Screening Services Revenue Share by Company (2021-2026) Table 7. Global Phage Display Library Screening Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Phage Display Library Screening Services Key Company Manufacturing Base & Headquarters Table 9. Global Phage Display Library Screening Services Company, Product Type & Application Table 10. Global Phage Display Library Screening Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Phage Display Library Screening Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Solid-Phase Screening Table 15. Significant Companies of Solution-Phase Screening Table 16. Significant Companies of Others Table 17. Global Phage Display Library Screening Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Phage Display Library Screening Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Phage Display Library Screening Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Phage Display Library Screening Services Sales Value Share by Type (2021-2026) Table 21. Global Phage Display Library Screening Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Therapeutic Development Table 23. Significant Companies of Diagnostic Development Table 24. Significant Companies of Research Table 25. Global Phage Display Library Screening Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Phage Display Library Screening Services Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Phage Display Library Screening Services Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Phage Display Library Screening Services Sales Value Share by Application (2021-2026) Table 29. Global Phage Display Library Screening Services Sales Value Share by Application (2027-2032) Table 30. Global Phage Display Library Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Phage Display Library Screening Services Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Phage Display Library Screening Services Sales Value Share by Region (2021-2026) Table 33. Global Phage Display Library Screening Services Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Phage Display Library Screening Services Sales Value Share by Region (2027-2032) Table 35. Global Phage Display Library Screening Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Phage Display Library Screening Services Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Phage Display Library Screening Services Sales Value Market Share by Country (2021-2026) Table 38. Global Phage Display Library Screening Services Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Phage Display Library Screening Services Sales Value Market Share by Country (2027-2032) Table 40. Creative Biolabs Company Information Table 41. Creative Biolabs Business Overview Table 42. Creative Biolabs Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Creative Biolabs Phage Display Library Screening Services Product Portfolio Table 44. Creative Biolabs Recent Development Table 45. Cusabio Company Information Table 46. Cusabio Business Overview Table 47. Cusabio Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Cusabio Phage Display Library Screening Services Product Portfolio Table 49. Cusabio Recent Development Table 50. Elabscience Company Information Table 51. Elabscience Business Overview Table 52. Elabscience Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Elabscience Phage Display Library Screening Services Product Portfolio Table 54. Elabscience Recent Development Table 55. Biomolecular Discovery Services Company Information Table 56. Biomolecular Discovery Services Business Overview Table 57. Biomolecular Discovery Services Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Biomolecular Discovery Services Phage Display Library Screening Services Product Portfolio Table 59. Biomolecular Discovery Services Recent Development Table 60. Sino Biological Company Information Table 61. Sino Biological Business Overview Table 62. Sino Biological Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Sino Biological Phage Display Library Screening Services Product Portfolio Table 64. Sino Biological Recent Development Table 65. VectorBuilder Company Information Table 66. VectorBuilder Business Overview Table 67. VectorBuilder Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. VectorBuilder Phage Display Library Screening Services Product Portfolio Table 69. VectorBuilder Recent Development Table 70. ProteoGenix Company Information Table 71. ProteoGenix Business Overview Table 72. ProteoGenix Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ProteoGenix Phage Display Library Screening Services Product Portfolio Table 74. ProteoGenix Recent Development Table 75. IRBM Company Information Table 76. IRBM Business Overview Table 77. IRBM Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. IRBM Phage Display Library Screening Services Product Portfolio Table 79. IRBM Recent Development Table 80. KMD Bioscience Company Information Table 81. KMD Bioscience Business Overview Table 82. KMD Bioscience Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. KMD Bioscience Phage Display Library Screening Services Product Portfolio Table 84. KMD Bioscience Recent Development Table 85. Fusion BioLabs Company Information Table 86. Fusion BioLabs Business Overview Table 87. Fusion BioLabs Phage Display Library Screening Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Fusion BioLabs Phage Display Library Screening Services Product Portfolio Table 89. Fusion BioLabs Recent Development Table 90. WuXi Biologics Company Information Table 91. WuXi Biologics Business Overview Table 92. WuXi Biologics Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. WuXi Biologics Phage Display Library Screening Services Product Portfolio Table 94. WuXi Biologics Recent Development Table 95. Selvita Company Information Table 96. Selvita Business Overview Table 97. Selvita Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Selvita Phage Display Library Screening Services Product Portfolio Table 99. Selvita Recent Development Table 100. Alpha Lifetech Company Information Table 101. Alpha Lifetech Business Overview Table 102. Alpha Lifetech Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Alpha Lifetech Phage Display Library Screening Services Product Portfolio Table 104. Alpha Lifetech Recent Development Table 105. Creative Peptides Company Information Table 106. Creative Peptides Business Overview Table 107. Creative Peptides Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Creative Peptides Phage Display Library Screening Services Product Portfolio Table 109. Creative Peptides Recent Development Table 110. MtoZ Biolabs Company Information Table 111. MtoZ Biolabs Business Overview Table 112. MtoZ Biolabs Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. MtoZ Biolabs Phage Display Library Screening Services Product Portfolio Table 114. MtoZ Biolabs Recent Development Table 115. Creative BioMart Microbe Company Information Table 116. Creative BioMart Microbe Business Overview Table 117. Creative BioMart Microbe Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Creative BioMart Microbe Phage Display Library Screening Services Product Portfolio Table 119. Creative BioMart Microbe Recent Development Table 120. Nanjing Zoonbio Biotechnology Company Information Table 121. Nanjing Zoonbio Biotechnology Business Overview Table 122. Nanjing Zoonbio Biotechnology Phage Display Library Screening Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Nanjing Zoonbio Biotechnology Phage Display Library Screening Services Product Portfolio Table 124. Nanjing Zoonbio Biotechnology Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Phage Display Library Screening Services Product Image Figure 2. Global Phage Display Library Screening Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phage Display Library Screening Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Phage Display Library Screening Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Solid-Phase Screening Image Figure 8. Solution-Phase Screening Image Figure 9. Others Image Figure 10. Global Phage Display Library Screening Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Phage Display Library Screening Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Phage Display Library Screening Services Sales Value Share by Type (2021-2032) Figure 13. Therapeutic Development Image Figure 14. Diagnostic Development Image Figure 15. Research Image Figure 16. Global Phage Display Library Screening Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Phage Display Library Screening Services Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Phage Display Library Screening Services Sales Value Share by Application (2021-2032) Figure 19. Global Phage Display Library Screening Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Phage Display Library Screening Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Phage Display Library Screening Services Sales Value (2021-2032) & (US$ Million) Figure 22. North America Phage Display Library Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Phage Display Library Screening Services Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Phage Display Library Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Phage Display Library Screening Services Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Phage Display Library Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Phage Display Library Screening Services Sales Value (2021-2032) & (US$ Million) Figure 28. South America Phage Display Library Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Phage Display Library Screening Services Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Phage Display Library Screening Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Phage Display Library Screening Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Solid-Phase Screening
  • Solution-Phase Screening
  • Others
Applications
  • Therapeutic Development
  • Diagnostic Development
  • Research
Companies covered
  • Creative Biolabs
  • Cusabio
  • Elabscience
  • Biomolecular Discovery Services
  • Sino Biological
  • VectorBuilder
  • ProteoGenix
  • IRBM
  • KMD Bioscience
  • Fusion BioLabs
  • WuXi Biologics
  • Selvita
  • Alpha Lifetech
  • Creative Peptides
  • MtoZ Biolabs
  • Creative BioMart Microbe
  • Nanjing Zoonbio Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Phage Display Library Screening Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Phage Display Library Screening Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Phage Display Library Screening Services Market Dynamics
  1. 2.1 Phage Display Library Screening Services Industry Trends
  2. 2.2 Phage Display Library Screening Services Industry Drivers
  3. 2.3 Phage Display Library Screening Services Industry Opportunities and Challenges
  4. 2.4 Phage Display Library Screening Services Industry Restraints
3 Phage Display Library Screening Services Market by Company
  1. 3.1 Global Phage Display Library Screening Services Company Revenue Ranking in 2025
  2. 3.2 Global Phage Display Library Screening Services Revenue by Company (2021-2026)
  3. 3.3 Global Phage Display Library Screening Services Company Ranking (2024-2026)
  4. 3.4 Global Phage Display Library Screening Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Phage Display Library Screening Services Company Product Type and Application
  6. 3.6 Global Phage Display Library Screening Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Phage Display Library Screening Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Phage Display Library Screening Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Phage Display Library Screening Services Market by Type
  1. 4.1 Phage Display Library Screening Services Type Introduction
  2. 4.1.1 Solid-Phase Screening
  3. 4.1.2 Solution-Phase Screening
  4. 4.1.3 Others
  5. 4.2 Global Phage Display Library Screening Services Sales Value by Type
  6. 4.2.1 Global Phage Display Library Screening Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Phage Display Library Screening Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Phage Display Library Screening Services Sales Value Share by Type (2021-2032)
5 Phage Display Library Screening Services Market by Application
  1. 5.1 Phage Display Library Screening Services Application Introduction
  2. 5.1.1 Therapeutic Development
  3. 5.1.2 Diagnostic Development
  4. 5.1.3 Research
  5. 5.2 Global Phage Display Library Screening Services Sales Value by Application
  6. 5.2.1 Global Phage Display Library Screening Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Phage Display Library Screening Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Phage Display Library Screening Services Sales Value Share by Application (2021-2032)
6 Phage Display Library Screening Services Regional Value Analysis
  1. 6.1 Global Phage Display Library Screening Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phage Display Library Screening Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Phage Display Library Screening Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Phage Display Library Screening Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Phage Display Library Screening Services Sales Value (2021-2032)
  7. 6.3.2 North America Phage Display Library Screening Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Phage Display Library Screening Services Sales Value (2021-2032)
  10. 6.4.2 Europe Phage Display Library Screening Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Phage Display Library Screening Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Phage Display Library Screening Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Phage Display Library Screening Services Sales Value (2021-2032)
  16. 6.6.2 South America Phage Display Library Screening Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Phage Display Library Screening Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Phage Display Library Screening Services Sales Value Share by Country, 2025 VS 2032
7 Phage Display Library Screening Services Country-level Value Analysis
  1. 7.1 Global Phage Display Library Screening Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phage Display Library Screening Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Phage Display Library Screening Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Phage Display Library Screening Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Phage Display Library Screening Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Phage Display Library Screening Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Phage Display Library Screening Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Creative Biolabs
  2. 8.1.1 Creative Biolabs Company Information
  3. 8.1.2 Creative Biolabs Business Overview
  4. 8.1.3 Creative Biolabs Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Creative Biolabs Phage Display Library Screening Services Product Portfolio
  6. 8.1.5 Creative Biolabs Recent Developments
  7. 8.2 Cusabio
  8. 8.2.1 Cusabio Company Information
  9. 8.2.2 Cusabio Business Overview
  10. 8.2.3 Cusabio Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cusabio Phage Display Library Screening Services Product Portfolio
  12. 8.2.5 Cusabio Recent Developments
  13. 8.3 Elabscience
  14. 8.3.1 Elabscience Company Information
  15. 8.3.2 Elabscience Business Overview
  16. 8.3.3 Elabscience Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Elabscience Phage Display Library Screening Services Product Portfolio
  18. 8.3.5 Elabscience Recent Developments
  19. 8.4 Biomolecular Discovery Services
  20. 8.4.1 Biomolecular Discovery Services Company Information
  21. 8.4.2 Biomolecular Discovery Services Business Overview
  22. 8.4.3 Biomolecular Discovery Services Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biomolecular Discovery Services Phage Display Library Screening Services Product Portfolio
  24. 8.4.5 Biomolecular Discovery Services Recent Developments
  25. 8.5 Sino Biological
  26. 8.5.1 Sino Biological Company Information
  27. 8.5.2 Sino Biological Business Overview
  28. 8.5.3 Sino Biological Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sino Biological Phage Display Library Screening Services Product Portfolio
  30. 8.5.5 Sino Biological Recent Developments
  31. 8.6 VectorBuilder
  32. 8.6.1 VectorBuilder Company Information
  33. 8.6.2 VectorBuilder Business Overview
  34. 8.6.3 VectorBuilder Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VectorBuilder Phage Display Library Screening Services Product Portfolio
  36. 8.6.5 VectorBuilder Recent Developments
  37. 8.7 ProteoGenix
  38. 8.7.1 ProteoGenix Company Information
  39. 8.7.2 ProteoGenix Business Overview
  40. 8.7.3 ProteoGenix Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ProteoGenix Phage Display Library Screening Services Product Portfolio
  42. 8.7.5 ProteoGenix Recent Developments
  43. 8.8 IRBM
  44. 8.8.1 IRBM Company Information
  45. 8.8.2 IRBM Business Overview
  46. 8.8.3 IRBM Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 IRBM Phage Display Library Screening Services Product Portfolio
  48. 8.8.5 IRBM Recent Developments
  49. 8.9 KMD Bioscience
  50. 8.9.1 KMD Bioscience Company Information
  51. 8.9.2 KMD Bioscience Business Overview
  52. 8.9.3 KMD Bioscience Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 KMD Bioscience Phage Display Library Screening Services Product Portfolio
  54. 8.9.5 KMD Bioscience Recent Developments
  55. 8.10 Fusion BioLabs
  56. 8.10.1 Fusion BioLabs Company Information
  57. 8.10.2 Fusion BioLabs Business Overview
  58. 8.10.3 Fusion BioLabs Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fusion BioLabs Phage Display Library Screening Services Product Portfolio
  60. 8.10.5 Fusion BioLabs Recent Developments
  61. 8.11 WuXi Biologics
  62. 8.11.1 WuXi Biologics Company Information
  63. 8.11.2 WuXi Biologics Business Overview
  64. 8.11.3 WuXi Biologics Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 WuXi Biologics Phage Display Library Screening Services Product Portfolio
  66. 8.11.5 WuXi Biologics Recent Developments
  67. 8.12 Selvita
  68. 8.12.1 Selvita Company Information
  69. 8.12.2 Selvita Business Overview
  70. 8.12.3 Selvita Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Selvita Phage Display Library Screening Services Product Portfolio
  72. 8.12.5 Selvita Recent Developments
  73. 8.13 Alpha Lifetech
  74. 8.13.1 Alpha Lifetech Company Information
  75. 8.13.2 Alpha Lifetech Business Overview
  76. 8.13.3 Alpha Lifetech Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alpha Lifetech Phage Display Library Screening Services Product Portfolio
  78. 8.13.5 Alpha Lifetech Recent Developments
  79. 8.14 Creative Peptides
  80. 8.14.1 Creative Peptides Company Information
  81. 8.14.2 Creative Peptides Business Overview
  82. 8.14.3 Creative Peptides Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Creative Peptides Phage Display Library Screening Services Product Portfolio
  84. 8.14.5 Creative Peptides Recent Developments
  85. 8.15 MtoZ Biolabs
  86. 8.15.1 MtoZ Biolabs Company Information
  87. 8.15.2 MtoZ Biolabs Business Overview
  88. 8.15.3 MtoZ Biolabs Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 MtoZ Biolabs Phage Display Library Screening Services Product Portfolio
  90. 8.15.5 MtoZ Biolabs Recent Developments
  91. 8.16 Creative BioMart Microbe
  92. 8.16.1 Creative BioMart Microbe Company Information
  93. 8.16.2 Creative BioMart Microbe Business Overview
  94. 8.16.3 Creative BioMart Microbe Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Creative BioMart Microbe Phage Display Library Screening Services Product Portfolio
  96. 8.16.5 Creative BioMart Microbe Recent Developments
  97. 8.17 Nanjing Zoonbio Biotechnology
  98. 8.17.1 Nanjing Zoonbio Biotechnology Company Information
  99. 8.17.2 Nanjing Zoonbio Biotechnology Business Overview
  100. 8.17.3 Nanjing Zoonbio Biotechnology Phage Display Library Screening Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Zoonbio Biotechnology Phage Display Library Screening Services Product Portfolio
  102. 8.17.5 Nanjing Zoonbio Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst